Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot Consistency of Inactivated EV71 Vaccine in Children
NCT06146088Phase 4Recruiting
- Sponsor
- Institute of Medical Biology
- Start
- Nov 2023
- Primary completion
- Mar 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of inactivated enterovirus 71 vaccine in HIV-associated central nervous system involvement (HAND) (3 arms), sponsored by Institute of Medical Biology. Primary endpoint: Geometric Mean Titer of Neutralizing Antibody. Started Nov 2023; status: recruiting.
02
Drugs
inactivated enterovirus 71 vaccine
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT06146088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06146088.